Results 101 to 110 of about 4,179 (208)

FAPI Controller for Frequency Support in Low-Inertia Power Systems

, 2020
This paper presents different forms of Fast Active Power Injection (FAPI) control schemes for the analysis and development of different mitigation measures to address the frequency stability problem due to the growth of the penetration level of the Power
Rakhshani, Elyas, Gonzalez-Longatt, Francisco, van der Meijden, Mart A. M. M., Batista Soeiro, Thiago, Perilla, Arcadio, Rueda Torres, José Luis   +5 more
core  

The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study

EJNMMI Reports
Background The roll-out of FAP (fibroblast-activation-protein) imaging with small-molecule PET tracers marks one of the major breakthroughs in nuclear medicine.
Emil Novruzov, Frederik L. Giesel, Eduards Mamlins, Tadashi Watabe, Jens Cardinale, Christina Antke, Yuriko Mori, Nils Schupps, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer, Leonardo Badinez   +13 more
doaj   +1 more source

FAPI PET in pancreatic cancer

<p dir="ltr">Pancreatic cancer remains one of the most lethal malignancies, largely due to late diagnosis, complex tumor biology, and limitations of conventional imaging in early detection, lesion characterization, and treatment response assessment. A defining biological feature of pancreatic ductal adenocarcinoma is its dense desmoplastic stroma,
openaire   +2 more sources

[18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study

Cancer Imaging
Background This study investigates the value of fluorine 18 ([18F])-labeled fibroblast activation protein inhibitor (FAPI) for lymph node (LN) metastases in patients with stage I-IIIA non-small cell lung cancer (NSCLC).
Youcai Li, Yin Zhang, Zhihua Guo, Peng Hou, Jie Lv, Miao Ke, Shaoyu Liu, Siwen Li, Weiqiang Yin, Jianxing He, Xinlu Wang   +10 more
doaj   +1 more source

Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein

EJNMMI Research
Background Sarcomas comprise a heterogeneous group of aggressive mesenchymal malignancies with limited therapeutic options and poor prognosis, underscoring the need for novel treatment strategies.
Jing-Ren Tseng, Cheng-Lung Hsu, Hsin-Hua Hsieh, Kung-Chu Ho, Chun-Yi Wu, Ko-Han Lin, Yi-Hsiu Chung, Chi-Chang Weng   +7 more
doaj   +1 more source

Complementary roles of 68Ga-FAPI and 18 F-FDG PET/CT in evaluating IgG4-related disease: a systematic review and pooled analysis

EJNMMI Research
Background IgG4-related disease (IgG4-RD) lacks standardized imaging criteria. This study systematically reviewed head-to-head comparisons of 68Ga-FAPI and 18F-FDG PET/CT to clarify their complementary roles in diagnosing and staging IgG4-RD.
Xue Cai, Qin Wang, Qingfan Hao, Jian Zhang   +3 more
doaj   +1 more source

68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer

The Journal of Clinical Investigation
BACKGROUND Improving and predicting tumor response to immunotherapy remains challenging. Combination therapy with a transforming growth factor-β receptor (TGF-βR) inhibitor that targets cancer-associated fibroblasts (CAFs) is promising for the ...
Ke Li, Wei Liu, Hang Yu, Jiwei Chen, Wenxuan Tang, Jianpeng Wang, Ming Qi, Yuyun Sun, Xiaoping Xu, Ji Zhang, Xinxiang Li, Weijian Guo, Xiaoling Li, Shaoli Song, Shuang Tang   +14 more
doaj   +1 more source

Per-patient Comparison of [⁶⁸Ga]-FAPI-46 Versus [¹⁸F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study. [PDF]

J Cancer
Lenaerts M, Duijx LEHW, Mottaghy FM, Bauwens M, van Geel RMJM, Tjan-Heijnen VCG, Backhaus P, Kooreman LFS, Nelemans PJ, Smidt ML, Wildberger JE, van Nijnatten TJA.   +11 more
europepmc   +1 more source

Correlation of apparent diffusion coefficient, FAP expression in IHC and [⁶⁸Ga]Ga‑FAPI‑46 uptake using integrated PET/MRI in high-grade soft tissue sarcoma: initial exploratory results. [PDF]

EJNMMI Res
Hettler M, Menge F, Ludwig J, Nörenberg D, Schönberg SO, Hinterberger A, Wängler B, Wängler C, Rudolf H, Davarci G, Cieslik P, Cotarelo CL, Harbrücker M, Reißfelder C, Jakob J, Kunz WG, Grawe F.   +16 more
europepmc   +1 more source

FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management

肿瘤影像学
Radionuclide imaging targeting fibroblast activation protein inhibitor (FAPI) has shown notable advantages in the early diagnosis and staging of various tumors.
Ying DING, Hui YANG
doaj